anonymous
Guest
anonymous
Guest
Any chance Vascepa will work on Covid..or that’s false hope and we’ll all be gone in a few months?
Any chance Vascepa will work on Covid..or that’s false hope and we’ll all be gone in a few months?
Think you’re hallucinating.Any chance Vascepa will work on Covid..or that’s false hope and we’ll all be gone in a few months?
You are selling against a generic. It's not rocket science that your days are numbered. Get out while you still have a job.
You hit the nail on the head!I think many people posting on our forum are not employees but investors trying to get a feel of what is happening on the sales front.
I do not think US is a completely lost cause. The skinny label argument can tip the scale in Amarins favors. A long shot but possible. If I were to guess Hikma will settle and bow out eventually for purely commercial reasons.
I think many people posting on our forum are not employees but investors trying to get a feel of what is happening on the sales front.
I do not think US is a completely lost cause. The skinny label argument can tip the scale in Amarins favors. A long shot but possible. If I were to guess Hikma will settle and bow out eventually for purely commercial reasons.
I think many people posting on our forum are not employees but investors trying to get a feel of what is happening on the sales front.
I do not think US is a completely lost cause. The skinny label argument can tip the scale in Amarins favors. A long shot but possible. If I were to guess Hikma will settle and bow out eventually for purely commercial reasons.